The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
A new study funded by the National Institute of Health and Care Research (NIHR) has shown that an artificial intelligence (AI) tool can accelerate the diagnosis of coeliac disease.
Peter Masonbrook from Faithful+Gould and Penny Anderson from Atkins discuss the role and importance of social value within the public and private sector.
Mark Reynolds, Chief Technology Officer at NHS Digital, talks about the unique challenges brought about by the pandemic, and how using data innovatively with the Shielded Patient List and Population Risk Assessment helped to identify and protect some of the most vulnerable in society.
Francesca Gargaglia, COO and CBO, Amity, argues that although social media platforms should be responsible for preventing the spread of COVID-19 misinformation, government agencies should build their own communities that build trust and promote well-informed discussions.
The US Food and Drug Administration (FDA) have approved a third Pfizer dose for people who are immunocompromised - despite the WHO asking countries to wait until 20% were double-vaccinated, globally.
Sir Andrew Pollard, head of the Oxford Vaccine Group, said on Tuesday (10 August) that herd immunity is "mythical" in relation to the Delta variant - as it still infects vaccinated individuals.
Physicians at University of California San Diego School of Medicine describe the first known case of a young, healthy adult who suffered brain inflammation after mild COVID-19 infection.
Lorna Green, Director of Enterprise and Growth, describes the role of the Innovation Agency and the AHSN Network across England and how health innovation is increasingly becoming integral to resolving the long-term challenges faced by the NHS.
According to a new study, fenofibrate, a drug used to treat abnormal levels of fatty substances in the blood, could reduce COVID-19 infection by up to 70%.
